Cardiology

Experts call for clearer care pathways to turn cardiovascular testing, biomarkers, and AI insights into earlier treatment and better prevention.

Experts explore how healthier transport, cleaner air, and coordinated urban policies could help cities prevent cardiovascular disease and reduce inequalities.

Severe obesity in heart failure was linked to increased respiratory failure and ventilation risk across chronic kidney disease stages.

A study of patients with heart failure found hyperkalaemia in 28%, with CKD significantly associated with elevated potassium. RAAS inhibitor and mineralocorticoid receptor antagonist prescriptions showed no association.

A randomised controlled trial found that nicorandil improved exercise capacity, coronary microcirculation, and quality of life in patients with heart failure with preserved ejection fraction and coronary microvascular dysfunction.

A multicentre Malaysian study identified six SCN5A gene variants among 40 patients with Brugada syndrome. Findings highlighted the potential role of genetic testing in risk stratification and family screening.

Remote ischemic conditioning reduced pulmonary fibrosis markers, inflammation, and tissue damage in a mouse model.

Artificial intelligence in cardiovascular medicine advances diagnostics, risk prediction, and clinical decision support.